| Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 RP Dellinger, MM Levy, A Rhodes, D Annane, H Gerlach, SM Opal, ... Critical care medicine 41 (2), 580-637, 2013 | 13836 | 2013 |
| Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 A Rhodes, LE Evans, W Alhazzani, MM Levy, M Antonelli, R Ferrer, ... Intensive care medicine 43, 304-377, 2017 | 10314 | 2017 |
| Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study KE Rudd, SC Johnson, KM Agesa, KA Shackelford, D Tsoi, DR Kievlan, ... The Lancet 395 (10219), 200-211, 2020 | 4269 | 2020 |
| Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 L Evans, A Rhodes, W Alhazzani, M Antonelli, CM Coopersmith, C French, ... Critical care medicine 49 (11), e1063-e1143, 2021 | 3580 | 2021 |
| Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, DC Angus, D Annane, ... Jama 324 (13), 1330-1341, 2020 | 1836 | 2020 |
| Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, DC Angus, D Annane, ... Jama 324 (13), 1330-1341, 2020 | 1836 | 2020 |
| Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial BM Tomazini, IS Maia, AB Cavalcanti, O Berwanger, RG Rosa, VC Veiga, ... Jama 324 (13), 1307-1316, 2020 | 1293 | 2020 |
| Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 AB Cavalcanti, FG Zampieri, RG Rosa, LCP Azevedo, VC Veiga, ... New England Journal of Medicine 383 (21), 2041-2052, 2020 | 1281 | 2020 |
| Recognizing sepsis as a global health priority—a WHO resolution K Reinhart, R Daniels, N Kissoon, FR Machado, RD Schachter, S Finfer New England Journal of Medicine 377 (5), 414-417, 2017 | 1180 | 2017 |
| Sepsis: a roadmap for future research J Cohen, JL Vincent, NKJ Adhikari, FR Machado, DC Angus, T Calandra, ... The Lancet infectious diseases 15 (5), 581-614, 2015 | 1125 | 2015 |
| A living WHO guideline on drugs for covid-19 A Agarwal, B Rochwerg, F Lamontagne, RAC Siemieniuk, T Agoritsas, ... | 939 | 2022 |
| Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup Surviving sepsis campaign: international guidelines for management of severe sepsis and septic … RP Dellinger, MM Levy, A Rhodes, D Annane, H Gerlach, SM Opal, ... Crit Care Med 41 (2), 580-637, 2013 | 926 | 2013 |
| Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized … AB Cavalcanti, ÉA Suzumura, LN Laranjeira, D de Moraes Paisani, ... Jama 318 (14), 1335-1345, 2017 | 712 | 2017 |
| Prevalence and outcomes of infection among patients in intensive care units in 2017 JL Vincent, Y Sakr, M Singer, I Martin-Loeches, FR Machado, JC Marshall, ... Jama 323 (15), 1478-1487, 2020 | 559 | 2020 |
| The surviving sepsis campaign bundles and outcome: results from the international multicentre prevalence study on sepsis (the IMPreSS study) A Rhodes, G Phillips, R Beale, M Cecconi, JD Chiche, D De Backer, ... Intensive care medicine 41, 1620-1628, 2015 | 475 | 2015 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 469 | 2021 |
| Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre … RD Lopes, RHM Furtado, AVS Macedo, B Bronhara, LP Damiani, ... The Lancet 397 (10291), 2253-2263, 2021 | 453 | 2021 |
| Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial VC Veiga, JAGG Prats, DLC Farias, RG Rosa, LK Dourado, FG Zampieri, ... bmj 372, 2021 | 424 | 2021 |
| Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update W Alhazzani, L Evans, F Alshamsi, MH Møller, M Ostermann, HC Prescott, ... Critical care medicine 49 (3), e219-e234, 2021 | 399 | 2021 |
| Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II … RHM Furtado, O Berwanger, HA Fonseca, TD Corrêa, LR Ferraz, ... The Lancet 396 (10256), 959-967, 2020 | 398 | 2020 |
